Postoperative Nausea and Vomiting Clinical Trial
Official title:
The Effect of Dexamethasone Versus Local Infiltration Technique on Postoperative Nausea and Vomiting After Tonsillectomy in Children: A Randomized Double-blind Clinical Trial
Tonsillectomy is one of the most frequent surgical operations performed in children [1-4]. It is usually associated with postoperative nausea and vomiting (PONV) with an incidence ranging from 23% to 73% [2]. Dexamethasone has been shown to be effective in reducing PONV after tonsillectomy using standardized anesthetic technique [2, 5-7]. Previous studies utilizing a different technique, the pre-incision infiltration of local anesthesia, had shown to decrease post-tonsillectomy pain, reduce analgesic consumption and provide a rapid return to normal activity [8, 9]. Given the effectiveness of dexamethasone and the pre-incision infiltration anesthetic technique, it would be beneficial to compare the effect of each on PONV.
Objective The purpose of this study is to compare the effect of dexamethasone versus the
pre-incision infiltration of local anesthesia in pediatric tonsillectomy procedures. The
primary outcome parameter of the study is the incidence of early PONV in the post-anesthesia
care unit (PACU) and late PONV on the floor and 5 days after discharge. The secondary
outcome is postoperative pain.
Methods Definitions Nausea is difficult to assess in children since they are not able to
verbalize their feelings. Retching, which is the unproductive effort to vomit (no expulsion
of gastric content), is considered an indicator of nausea. Therefore, for the purpose of
this study, PONV is defined as vomiting and/or retching. Early PONV is defined as vomiting
and/or retching in the PACU. Late PONV is defined as vomiting and/or retching on the floor
and 5 days after discharge.
Study design The study will be conducted prospectively, using a randomized double-blinded
placebo-controlled design. Thus, neither the surgeon nor the anesthesiologist will be aware
of the injected solution content and they will not be involved in data collection. The
patients and the residents who will collect the data will also be unaware of the patient's
assigned group.
Sampling
Patients scheduled for total or partial tonsillectomy with or without adenoidectomy starting
from January 2015, whose ages range between 2 to 13 years will be included in the study.
Exclusion criteria consisted of patients who received antiemetics, steroids,
antihistaminics, or psychoactive drugs within 24 hours before surgery. Patients who are
suspected to have malignant neoplasm and signs of acute pharyngeal infection will be
excluded from the study. Moreover, patients who have asthma, diabetes mellitus, bleeding
problems, and allergy towards bupivacaine are excluded as well.
Upon meeting the eligibility criteria and signing the consent form, patients will be
allocated randomly into two equal groups using the sealed envelope method. Both groups will
have general anesthesia (GA) and endotracheal intubation. Then, one group will receive
dexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration. The other group will
receive pre-incision infiltration of 1.5 ml local anesthesia mixture in each tonsil and an
equivalent volume of IV saline.
Anesthetic techniques General anesthesia General anesthesia will be induced by intravenous
fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation
facilitated by atracurium (0.5 mg kg-1). Anesthesia will be subsequently maintained with
sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%. The sevoflurane
concentration will be adjusted with the intention of keeping the heart rate and blood
pressure within 25% of pre-induction values [8, 9].
Modified infiltration technique The infiltration will be performed by the anesthetist using
a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for
each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine
1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg
ml-1 [8, 9].
Surgical techniques The tonsillectomy techniques were monopolar electrocautery or cold
dissection. The degree of tonsillar enlargement was graded as follows: tonsils within
tonsillar folds; tonsils just outside tonsillar folds; tonsils well outside tonsillar folds
but not reaching uvula; tonsils reaching uvula or past uvula [3]. Towards the end of the
surgery, gastric contents of all patients will be suctioned via an orogastric tube prior to
extubation [10]. Patients were extubated when fully awake. Systemic IV paracetamol (15
mg/kg) was given to all patients.
Data collection Pre- and intraoperative data include: patient's demographics, surgical
technique, amount of fentanyl consumed, heart rate, mean arterial pressure and oxygen
concentration in addition to surgery duration. Data to be collected postoperatively in the
PACU (by PACU nurse) and floor included: frequency of PONV, pain scores, antiemetic and
analgesic consumption as well as patients' and surgeons' satisfaction. PONV will be assessed
using questions adopted from Rhodes Index of Nausea, Vomiting and Retching (RINVR) but was
modified for pediatrics [11, 12]. For children aged five years and older, pain will be
measured using the Visual Analog Scale (VAS) with a score of 0 denoting no pain and 10
maximum possible pains. For children less than five years of age, the Wong-Baker faces pain
scale will be used. Pain will be assessed at rest in addition to when opening the jaw,
swallowing, eating soft and ordinary food. The parents will be told that they will be
contacted through phone calls after their hospital discharge on a daily basis and will be
asked about the pain intensity and analgesic consumption of their child. Patients will be
followed-up by anesthesiology resident for five postoperative days.
Parents' satisfaction will be based on quality of communication and care provided by the
anesthesiologists and nurses, in addition to parental opinion of the child's recollection
and the overall experience. Surgeon satisfaction will be assessed using patients' comfort
and number of phone calls made by parents.
Since the study is double-blind, neither the surgeon nor the anesthesiologist are aware of
the injected solution content and were not involved in data collection. The patients and the
trained nurses who collect the data are also unaware of the patient's assigned group.
Postoperative pain management For pain scores >5, 1-2 mg/kg of tramadol hydrochloride
(Tramal drops, Laboratoire, Grunenthal, Aachen-Germany) would be given. If pain score is
between 4 and 5, 15mg/kg intravenous propacetamol hydrochloride (Pro-Dafalgan Laboratoires,
UPSA, Agen, France) will be provided. Paracetamol suppository 350 mg (Tylenol CILAG SA,
Schaffhouse, Switzerland) will be administered for children with pain scores <4. Paracetamol
suppository 350 mg is prescribed systematically two to four times a day as needed to all
discharged children. If they experience pain with a score >5, tramadol hydrochloride will be
prescribed.
Statistical Analysis Data will be statistically analyzed by chi-square test and t-test
(two-tailed). P-value < 0.05 is considered significant. Results will be reported as mean and
standard deviation (SD), or frequency and percentage as appropriate.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04466046 -
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
|
||
| Completed |
NCT03139383 -
Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery
|
N/A | |
| Recruiting |
NCT04069806 -
Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section
|
N/A | |
| Completed |
NCT04043247 -
Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting
|
N/A | |
| Terminated |
NCT01975727 -
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
|
Phase 2 | |
| Completed |
NCT03662672 -
Rib Raising for Post-operative Ileus
|
N/A | |
| Completed |
NCT00090155 -
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
|
Phase 3 | |
| Recruiting |
NCT05375721 -
Prevention of PONV With Traditional Chinese Medicine
|
N/A | |
| Completed |
NCT02480088 -
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
|
Phase 4 | |
| Recruiting |
NCT06137027 -
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
|
Early Phase 1 | |
| Not yet recruiting |
NCT05529004 -
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
|
Phase 2 | |
| Completed |
NCT02944942 -
Risk Factors for Postoperative Nausea/Vomiting
|
N/A | |
| Recruiting |
NCT02571153 -
Low Doses of Ketamine and Postoperative Quality of Recovery
|
Phase 4 | |
| Completed |
NCT02550795 -
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
|
N/A | |
| Completed |
NCT02449291 -
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
|
Phase 3 | |
| Recruiting |
NCT01442012 -
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
|
N/A | |
| Completed |
NCT01478165 -
Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting
|
N/A | |
| Unknown status |
NCT01268748 -
Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain
|
N/A | |
| Completed |
NCT02143531 -
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
|
Phase 4 | |
| Completed |
NCT00734929 -
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
|
Phase 4 |